Nucleic acid-based vaccines targeting respiratory syncytial virus: Delivering the goods

Respiratory syncytial virus (RSV) is a massive medical burden on a global scale. Infants, children and the elderly represent the vulnerable populations. Currently there is no approved vaccine to protect against the disease. Vaccine development has been hindered by several factors including vaccine e...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Hum Vaccin Immunother
Asıl Yazarlar: Smith, Trevor R. F., Schultheis, Katherine, Broderick, Kate E.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Taylor & Francis 2017
Konular:
Commentary
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5703370/
https://ncbi.nlm.nih.gov/pubmed/28881156
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2017.1363134
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller